Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Patterson AW"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ting PY; Novartis Biomedical Research, Cambridge, MA, USA., Borikar S; Novartis Biomedical Research, Cambridge, MA, USA., Kerrigan JR; Novartis Biomedical Research, Cambridge, MA, USA., Thomsen NM; Novartis Biomedical Research, Cambridge, MA, USA., Aghania E; Novartis Biomedical Research, Cambridge, MA, USA., Hinman AE; Novartis Biomedical Research, Cambridge, MA, USA., Reyes A; Novartis Biomedical Research, Basel, Switzerland., Pizzato N; Novartis Biomedical Research, Basel, Switzerland., Fodor BD; Novartis Biomedical Research, Basel, Switzerland., Wu F; Novartis Biomedical Research, Basel, Switzerland., Belew MS; Novartis Biomedical Research, Cambridge, MA, USA., Mao X; Novartis Biomedical Research, Cambridge, MA, USA., Wang J; Novartis Biomedical Research, Cambridge, MA, USA., Chitnis S; Novartis Biomedical Research, Cambridge, MA, USA., Niu W; Novartis Biomedical Research, Cambridge, MA, USA., Hachey A; Novartis Biomedical Research, Cambridge, MA, USA., Cobb JS; Novartis Biomedical Research, Cambridge, MA, USA., Savage NA; Novartis Biomedical Research, Cambridge, MA, USA., Burke A; Novartis Biomedical Research, Cambridge, MA, USA., Paulk J; Novartis Biomedical Research, Cambridge, MA, USA., Dovala D; Novartis Biomedical Research, Emeryville, CA, USA., Lin J; Novartis Biomedical Research, Emeryville, CA, USA., Clifton MC; Novartis Biomedical Research, Emeryville, CA, USA., Ornelas E; Novartis Biomedical Research, Emeryville, CA, USA., Ma X; Novartis Biomedical Research, Emeryville, CA, USA., Ware NF; Novartis Biomedical Research, Cambridge, MA, USA., Sanchez CC; Novartis Biomedical Research, Cambridge, MA, USA., Taraszka J; Novartis Biomedical Research, Cambridge, MA, USA., Terranova R; Novartis Biomedical Research, Basel, Switzerland., Knehr J; Novartis Biomedical Research, Basel, Switzerland., Altorfer M; Novartis Biomedical Research, Basel, Switzerland., Barnes SW; Novartis Biomedical Research, San Diego, CA, USA., Beckwith REJ; Novartis Biomedical Research, Cambridge, MA, USA., Solomon JM; Novartis Biomedical Research, Cambridge, MA, USA., Dales NA; Novartis Biomedical Research, Cambridge, MA, USA., Patterson AW; Novartis Biomedical Research, Cambridge, MA, USA., Wagner J; Novartis Biomedical Research, Basel, Switzerland., Bouwmeester T; Novartis Biomedical Research, Basel, Switzerland., Dranoff G; Novartis Biomedical Research, Cambridge, MA, USA., Stevenson SC; Novartis Biomedical Research, Cambridge, MA, USA., Bradner JE; Novartis Biomedical Research, Cambridge, MA, USA.
Publikováno v:
Science (New York, N.Y.) [Science] 2024 Jul 05; Vol. 385 (6704), pp. 91-99. Date of Electronic Publication: 2024 Jul 04.
Autor:
Hoegenauer K; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4002 Basel, Switzerland., An S; Chemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States., Axford J; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States., Benander C; Chemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States., Bergsdorf C; Chemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4002 Basel, Switzerland., Botsch J; Chemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4002 Basel, Switzerland., Chau S; Chemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4002 Basel, Switzerland., Fernández C; Chemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4002 Basel, Switzerland., Gleim S; Chemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States., Hassiepen U; Chemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4002 Basel, Switzerland., Hunziker J; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4002 Basel, Switzerland., Joly E; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4002 Basel, Switzerland., Keller A; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4002 Basel, Switzerland., Lopez Romero S; Chemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4002 Basel, Switzerland., Maher R; Chemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States., Mangold AS; Chemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4002 Basel, Switzerland., Mickanin C; Chemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States., Mihalic M; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4002 Basel, Switzerland., Neuner P; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4002 Basel, Switzerland., Patterson AW; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States., Perruccio F; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4002 Basel, Switzerland., Roggo S; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4002 Basel, Switzerland., Scesa J; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4002 Basel, Switzerland., Schröder M; Chemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4002 Basel, Switzerland., Shkoza D; Chemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States., Thai B; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4002 Basel, Switzerland., Vulpetti A; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4002 Basel, Switzerland., Renatus M; Chemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4002 Basel, Switzerland., Reece-Hoyes JS; Chemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States.
Publikováno v:
ACS medicinal chemistry letters [ACS Med Chem Lett] 2023 Nov 13; Vol. 14 (12), pp. 1631-1639. Date of Electronic Publication: 2023 Nov 13 (Print Publication: 2023).
Autor:
Regard JB; Cardiovascular and Metabolic Diseases, Cambridge, MA, USA., Harrison TJ; Global Discovery Chemistry, Cambridge, MA, USA., Axford J; Global Discovery Chemistry, Cambridge, MA, USA., Axford L; Cardiovascular and Metabolic Diseases, Cambridge, MA, USA. Electronic address: laura.axford@novartis.com., Lee L; Cardiovascular and Metabolic Diseases, Cambridge, MA, USA., Ren X; Cardiovascular and Metabolic Diseases, Cambridge, MA, USA., Deng L; PK Sciences, Cambridge, MA, USA., Reynolds A; Technical R&D, Cambridge, MA, USA., Mao J; Global Discovery Chemistry, Cambridge, MA, USA., Liu Q; Global Discovery Chemistry, Cambridge, MA, USA., Patnaik A; Global Discovery Chemistry, Cambridge, MA, USA., Cohick E; Cardiovascular and Metabolic Diseases, Cambridge, MA, USA., Hollis-Symynkywicz M; Cardiovascular and Metabolic Diseases, Cambridge, MA, USA., Loi S; Cardiovascular and Metabolic Diseases, Cambridge, MA, USA., Riek S; Novartis Institutes for BioMedical Research, Autoimmunity, Transplantation and Inflammation, Switzlerland., McKeever U; Novartis Institutes for BioMedical Research, Autoimmunity, Transplantation and Inflammation, Switzlerland., Dunstan D; Global Discovery Chemistry, Cambridge, MA, USA., Sung M; Global Discovery Chemistry, Cambridge, MA, USA., Ware NF; Global Discovery Chemistry, Cambridge, MA, USA., Brown AP; Preclinical Safety, Novartis Institutes for BioMedical Research, Fabrikstrasse 2 Novartis Campus, Basel CH-4056, Switzerland., Hamann LG; Global Discovery Chemistry, Cambridge, MA, USA., Marcinkeviciene J; Cardiovascular and Metabolic Diseases, Cambridge, MA, USA., Patterson AW; Global Discovery Chemistry, Cambridge, MA, USA., Marro ML; Cardiovascular and Metabolic Diseases, Cambridge, MA, USA.
Publikováno v:
Biochemical pharmacology [Biochem Pharmacol] 2023 Mar; Vol. 209, pp. 115418. Date of Electronic Publication: 2023 Jan 21.
Autor:
Peterson AS, Patterson AW
Publikováno v:
Optometry and vision science : official publication of the American Academy of Optometry [Optom Vis Sci] 2022 Apr 01; Vol. 99 (4), pp. 383-388.
Autor:
Patnaik A; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Cambridge, MA 02139, United States. Electronic address: anup.patnaik@novartis.com., Axford L; Cardiovascular and Metabolic Diseases, Novartis Institutes for BioMedical Research, Cambridge, MA 02139, United States., Deng L; PK Sciences, Novartis Institutes for BioMedical Research, Cambridge, MA 02139, United States., Cohick E; Cardiovascular and Metabolic Diseases, Novartis Institutes for BioMedical Research, Cambridge, MA 02139, United States., Ren X; Cardiovascular and Metabolic Diseases, Novartis Institutes for BioMedical Research, Cambridge, MA 02139, United States., Loi S; Cardiovascular and Metabolic Diseases, Novartis Institutes for BioMedical Research, Cambridge, MA 02139, United States., Kecman S; Cardiovascular and Metabolic Diseases, Novartis Institutes for BioMedical Research, Cambridge, MA 02139, United States., Hollis-Symynkywicz M; Cardiovascular and Metabolic Diseases, Novartis Institutes for BioMedical Research, Cambridge, MA 02139, United States., Harrison TJ; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Cambridge, MA 02139, United States., Papillon JPN; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Cambridge, MA 02139, United States., Dales N; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Cambridge, MA 02139, United States., Hamann LG; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Cambridge, MA 02139, United States., Lee L; Cardiovascular and Metabolic Diseases, Novartis Institutes for BioMedical Research, Cambridge, MA 02139, United States., Regard JB; Cardiovascular and Metabolic Diseases, Novartis Institutes for BioMedical Research, Cambridge, MA 02139, United States., Marcinkeviciene J; Cardiovascular and Metabolic Diseases, Novartis Institutes for BioMedical Research, Cambridge, MA 02139, United States., Marro ML; Cardiovascular and Metabolic Diseases, Novartis Institutes for BioMedical Research, Cambridge, MA 02139, United States., Patterson AW; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Cambridge, MA 02139, United States. Electronic address: andrew.patterson@novartis.com.
Publikováno v:
Bioorganic & medicinal chemistry [Bioorg Med Chem] 2020 Jun 15; Vol. 28 (12), pp. 115548. Date of Electronic Publication: 2020 May 12.
Autor:
Marro ML; Cardiovascular and Metabolic Diseases (M.L.M., L.L., X.R., L.Ax., M.H.-S., N.C., D.C., L.Am., S.L., L.Z., T.H., J.M., J.B.R.), Global Discovery Chemistry (A.W.P., A.P., T.J.H., J.P.N.P., L.G.H.), PK Sciences (L.D.), Technical R&D (A.R.), and Chemical Biology and Therapeutics (J.B.), Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., Patterson AW; Cardiovascular and Metabolic Diseases (M.L.M., L.L., X.R., L.Ax., M.H.-S., N.C., D.C., L.Am., S.L., L.Z., T.H., J.M., J.B.R.), Global Discovery Chemistry (A.W.P., A.P., T.J.H., J.P.N.P., L.G.H.), PK Sciences (L.D.), Technical R&D (A.R.), and Chemical Biology and Therapeutics (J.B.), Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., Lee L; Cardiovascular and Metabolic Diseases (M.L.M., L.L., X.R., L.Ax., M.H.-S., N.C., D.C., L.Am., S.L., L.Z., T.H., J.M., J.B.R.), Global Discovery Chemistry (A.W.P., A.P., T.J.H., J.P.N.P., L.G.H.), PK Sciences (L.D.), Technical R&D (A.R.), and Chemical Biology and Therapeutics (J.B.), Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., Deng L; Cardiovascular and Metabolic Diseases (M.L.M., L.L., X.R., L.Ax., M.H.-S., N.C., D.C., L.Am., S.L., L.Z., T.H., J.M., J.B.R.), Global Discovery Chemistry (A.W.P., A.P., T.J.H., J.P.N.P., L.G.H.), PK Sciences (L.D.), Technical R&D (A.R.), and Chemical Biology and Therapeutics (J.B.), Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., Reynolds A; Cardiovascular and Metabolic Diseases (M.L.M., L.L., X.R., L.Ax., M.H.-S., N.C., D.C., L.Am., S.L., L.Z., T.H., J.M., J.B.R.), Global Discovery Chemistry (A.W.P., A.P., T.J.H., J.P.N.P., L.G.H.), PK Sciences (L.D.), Technical R&D (A.R.), and Chemical Biology and Therapeutics (J.B.), Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., Ren X; Cardiovascular and Metabolic Diseases (M.L.M., L.L., X.R., L.Ax., M.H.-S., N.C., D.C., L.Am., S.L., L.Z., T.H., J.M., J.B.R.), Global Discovery Chemistry (A.W.P., A.P., T.J.H., J.P.N.P., L.G.H.), PK Sciences (L.D.), Technical R&D (A.R.), and Chemical Biology and Therapeutics (J.B.), Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., Axford L; Cardiovascular and Metabolic Diseases (M.L.M., L.L., X.R., L.Ax., M.H.-S., N.C., D.C., L.Am., S.L., L.Z., T.H., J.M., J.B.R.), Global Discovery Chemistry (A.W.P., A.P., T.J.H., J.P.N.P., L.G.H.), PK Sciences (L.D.), Technical R&D (A.R.), and Chemical Biology and Therapeutics (J.B.), Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., Patnaik A; Cardiovascular and Metabolic Diseases (M.L.M., L.L., X.R., L.Ax., M.H.-S., N.C., D.C., L.Am., S.L., L.Z., T.H., J.M., J.B.R.), Global Discovery Chemistry (A.W.P., A.P., T.J.H., J.P.N.P., L.G.H.), PK Sciences (L.D.), Technical R&D (A.R.), and Chemical Biology and Therapeutics (J.B.), Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., Hollis-Symynkywicz M; Cardiovascular and Metabolic Diseases (M.L.M., L.L., X.R., L.Ax., M.H.-S., N.C., D.C., L.Am., S.L., L.Z., T.H., J.M., J.B.R.), Global Discovery Chemistry (A.W.P., A.P., T.J.H., J.P.N.P., L.G.H.), PK Sciences (L.D.), Technical R&D (A.R.), and Chemical Biology and Therapeutics (J.B.), Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., Casson N; Cardiovascular and Metabolic Diseases (M.L.M., L.L., X.R., L.Ax., M.H.-S., N.C., D.C., L.Am., S.L., L.Z., T.H., J.M., J.B.R.), Global Discovery Chemistry (A.W.P., A.P., T.J.H., J.P.N.P., L.G.H.), PK Sciences (L.D.), Technical R&D (A.R.), and Chemical Biology and Therapeutics (J.B.), Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., Custeau D; Cardiovascular and Metabolic Diseases (M.L.M., L.L., X.R., L.Ax., M.H.-S., N.C., D.C., L.Am., S.L., L.Z., T.H., J.M., J.B.R.), Global Discovery Chemistry (A.W.P., A.P., T.J.H., J.P.N.P., L.G.H.), PK Sciences (L.D.), Technical R&D (A.R.), and Chemical Biology and Therapeutics (J.B.), Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., Ames L; Cardiovascular and Metabolic Diseases (M.L.M., L.L., X.R., L.Ax., M.H.-S., N.C., D.C., L.Am., S.L., L.Z., T.H., J.M., J.B.R.), Global Discovery Chemistry (A.W.P., A.P., T.J.H., J.P.N.P., L.G.H.), PK Sciences (L.D.), Technical R&D (A.R.), and Chemical Biology and Therapeutics (J.B.), Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., Loi S; Cardiovascular and Metabolic Diseases (M.L.M., L.L., X.R., L.Ax., M.H.-S., N.C., D.C., L.Am., S.L., L.Z., T.H., J.M., J.B.R.), Global Discovery Chemistry (A.W.P., A.P., T.J.H., J.P.N.P., L.G.H.), PK Sciences (L.D.), Technical R&D (A.R.), and Chemical Biology and Therapeutics (J.B.), Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., Zhang L; Cardiovascular and Metabolic Diseases (M.L.M., L.L., X.R., L.Ax., M.H.-S., N.C., D.C., L.Am., S.L., L.Z., T.H., J.M., J.B.R.), Global Discovery Chemistry (A.W.P., A.P., T.J.H., J.P.N.P., L.G.H.), PK Sciences (L.D.), Technical R&D (A.R.), and Chemical Biology and Therapeutics (J.B.), Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., Honda T; Cardiovascular and Metabolic Diseases (M.L.M., L.L., X.R., L.Ax., M.H.-S., N.C., D.C., L.Am., S.L., L.Z., T.H., J.M., J.B.R.), Global Discovery Chemistry (A.W.P., A.P., T.J.H., J.P.N.P., L.G.H.), PK Sciences (L.D.), Technical R&D (A.R.), and Chemical Biology and Therapeutics (J.B.), Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., Blank J; Cardiovascular and Metabolic Diseases (M.L.M., L.L., X.R., L.Ax., M.H.-S., N.C., D.C., L.Am., S.L., L.Z., T.H., J.M., J.B.R.), Global Discovery Chemistry (A.W.P., A.P., T.J.H., J.P.N.P., L.G.H.), PK Sciences (L.D.), Technical R&D (A.R.), and Chemical Biology and Therapeutics (J.B.), Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., Harrison TJ; Cardiovascular and Metabolic Diseases (M.L.M., L.L., X.R., L.Ax., M.H.-S., N.C., D.C., L.Am., S.L., L.Z., T.H., J.M., J.B.R.), Global Discovery Chemistry (A.W.P., A.P., T.J.H., J.P.N.P., L.G.H.), PK Sciences (L.D.), Technical R&D (A.R.), and Chemical Biology and Therapeutics (J.B.), Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., Papillon JPN; Cardiovascular and Metabolic Diseases (M.L.M., L.L., X.R., L.Ax., M.H.-S., N.C., D.C., L.Am., S.L., L.Z., T.H., J.M., J.B.R.), Global Discovery Chemistry (A.W.P., A.P., T.J.H., J.P.N.P., L.G.H.), PK Sciences (L.D.), Technical R&D (A.R.), and Chemical Biology and Therapeutics (J.B.), Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., Hamann LG; Cardiovascular and Metabolic Diseases (M.L.M., L.L., X.R., L.Ax., M.H.-S., N.C., D.C., L.Am., S.L., L.Z., T.H., J.M., J.B.R.), Global Discovery Chemistry (A.W.P., A.P., T.J.H., J.P.N.P., L.G.H.), PK Sciences (L.D.), Technical R&D (A.R.), and Chemical Biology and Therapeutics (J.B.), Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., Marcinkeviciene J; Cardiovascular and Metabolic Diseases (M.L.M., L.L., X.R., L.Ax., M.H.-S., N.C., D.C., L.Am., S.L., L.Z., T.H., J.M., J.B.R.), Global Discovery Chemistry (A.W.P., A.P., T.J.H., J.P.N.P., L.G.H.), PK Sciences (L.D.), Technical R&D (A.R.), and Chemical Biology and Therapeutics (J.B.), Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., Regard JB; Cardiovascular and Metabolic Diseases (M.L.M., L.L., X.R., L.Ax., M.H.-S., N.C., D.C., L.Am., S.L., L.Z., T.H., J.M., J.B.R.), Global Discovery Chemistry (A.W.P., A.P., T.J.H., J.P.N.P., L.G.H.), PK Sciences (L.D.), Technical R&D (A.R.), and Chemical Biology and Therapeutics (J.B.), Novartis Institutes for BioMedical Research, Cambridge, Massachusetts jean.regard@novartis.com.
Publikováno v:
The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2018 Oct; Vol. 367 (1), pp. 147-154. Date of Electronic Publication: 2018 Aug 03.